Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 272 | 295 | 204 | 291 | 555 |
| Cost of Goods | 109 | 124 | 71 | 117 | 300 |
| Gross Profit | 163 | 171 | 133 | 174 | 255 |
| Operating Expenses | 2,668 | 2,465 | 3,202 | 2,782 | 2,694 |
| Operating Income | -2,396 | -2,170 | -2,998 | -2,491 | -2,139 |
| Other Income | 18 | -715 | -2,591 | 40 | 64 |
| Pre-tax Income | -2,378 | -2,885 | -5,589 | -2,451 | -2,075 |
| Net Income Continuous | -2,378 | -2,885 | -5,589 | -2,451 | -2,075 |
| Net Income | $-2,378 | $-2,885 | $-5,589 | $-2,451 | $-2,075 |
| EPS Basic Total Ops | -0.03 | -0.04 | -0.09 | -0.05 | -0.04 |
| EPS Basic Continuous Ops | -0.03 | -0.05 | -0.09 | -0.05 | -0.04 |
| EPS Diluted Total Ops | -0.03 | -0.04 | -0.09 | -0.05 | -0.04 |
| EPS Diluted Continuous Ops | -0.03 | -0.05 | -0.09 | -0.05 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.03 | -0.04 | -0.09 | N/A | N/A |
| EBITDA(a) | $-2,234 | $-2,006 | $-2,838 | $-2,333 | $-1,984 |